1-3 of 3
Luis Hernández-Nieto
Close
Sort by
Journal Articles

Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

CME
Alberto Alvarez-Larrán, Francisco Cervantes, Arturo Pereira, Eduardo Arellano-Rodrigo, Virginia Pérez-Andreu, Juan-Carlos Hernández-Boluda, Ramón Ayats, Carlos Salvador, Ana Muntañola, Beatriz Bellosillo, Vicente Vicente, Luis Hernández-Nieto, Carmen Burgaleta, Blanca Xicoy, Carlos Besses
Journal: Blood
Blood (2010) 116 (8): 1205–1210.
https://doi.org/10.1182/blood-2010-01-263319
Published: 2010
Journal Articles

Response Predictive Factors to Anagrelide in Essential Thrombocythemia Diagnosed Patients.

Carlos Besses, MD, PhD, Manuel Giralt, MD, PhD, Luis Hernandez-Nieto, MD, PhD, Carmen Burgaleta, MD, PhD, Victor Navas, MD, PhD, Gema Ramirez, MD, PhD, Vicente Vicente, MD, PhD, Felix Carbonell, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4649.
https://doi.org/10.1182/blood.V110.11.4649.4649
Published: 2007
Journal Articles

Essential Thrombocythemia in Young Individuals: Frequency and Risk Factors for Vascular Events and Evolution to Myelofibrosis in 126 Patients.

Alberto Alvarez-Larran, MD, Francisco Cervantes, MD, Beatriz Bellosillo, PhD, Manuel Giralt, MD, Antoni Julia, MD, Juan Carlos Hernandez-Boluda, MD, Luis Hernandez-Nieto, MD, Victoria Clapes, MD, Carmen Burgaleta, MD, Alba Bosch, MD, Carlos Salvador, MD, Eduardo Arellano-Rodrigo, MD, Dolors Colomer, PhD, Carlos Besses, MD
Journal: Blood
Blood (2006) 108 (11): 3598.
https://doi.org/10.1182/blood.V108.11.3598.3598
Published: 2006